Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.

Biotechnology

Health Care

Entact Bio

Victoria Richon

Stefanie Schalm

Victor Serebrov

Simon Bushell

Paul Perkins

Owen Smith

Elma Kadic

Bob Soh

The Leadership Team at Entact Bio is responsible for setting the strategic direction and overseeing the execution of the company’s mission to develop innovative medications that enhance protein function. Comprising experts in program biology, molecular discovery, and biological sciences, the team collaborates to guide research initiatives, foster innovation within the proprietary EncompassTM platform, and drive the company through its preclinical stages towards successful drug development. Their collective leadership facilitates alignment across functions and ensures the rigorous advancement of the proprietary ENTACTM medicines.

Leadership Team

Biological Sciences Research

Research and Development

Leadership Team

About

Team members

Other teams at Entact Bio

Biological Sciences Research

Research and Development